BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30544372)

  • 1. Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report.
    Yang D; Zhang WP; Yang JM; He MX; Cheng C; Chen J
    Medicine (Baltimore); 2018 Dec; 97(49):e13093. PubMed ID: 30544372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case report.
    Wu P; Ma T; Chen Y; Wang F; Chen Y; Gao J; Zhou Z; Jia Y
    Anticancer Drugs; 2021 Sep; 32(8):886-889. PubMed ID: 34145178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report.
    Hu S; Zou D; Zhou D; Zhang Y; Wang W; Zhang W
    Medicine (Baltimore); 2020 Oct; 99(43):e22788. PubMed ID: 33120793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
    Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy.
    Li Q; Huang J; Ou Y; Li Y; Wu Y
    Immunotherapy; 2019 Mar; 11(4):265-272. PubMed ID: 30606076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
    Tian C; Chen Z; Li Y
    J Int Med Res; 2020 Jul; 48(7):300060520936053. PubMed ID: 32643971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
    Yang X; Min X; He W
    Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway.
    Wu C; Chen S; Wu Z; Xue J; Zhang W; Wang S; Xindong Zhao ; Wu S
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):98. PubMed ID: 38381215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
    Wang Y; Xue H; Song W; Xiao S; Jing F; Dong T; Wang L
    Hematol Oncol; 2022 Oct; 40(4):617-625. PubMed ID: 35165928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20.
    Guan XW; Wang HQ; Ban WW; Chang Z; Chen HZ; Jia L; Liu FT
    Cell Death Dis; 2020 Jan; 11(1):20. PubMed ID: 31907371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.
    Shi Y; Dong M; Hong X; Zhang W; Feng J; Zhu J; Yu L; Ke X; Huang H; Shen Z; Fan Y; Li W; Zhao X; Qi J; Huang H; Zhou D; Ning Z; Lu X
    Ann Oncol; 2015 Aug; 26(8):1766-71. PubMed ID: 26105599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma.
    Sohn BS; Kim SM; Yoon DH; Kim S; Lee DH; Kim JH; Lee SW; Huh J; Suh C
    Ann Hematol; 2012 Nov; 91(11):1731-9. PubMed ID: 22752193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper gastrointestinal bleeding caused by direct invasion of diffuse large B-cell lymphoma into the stomach in a patient with HIV infection: A case report.
    Kim MS; Park JH; Kim JY; Lim SN; Lee J
    Medicine (Baltimore); 2019 Jul; 98(28):e16363. PubMed ID: 31305432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma.
    Zhang MC; Fang Y; Wang L; Cheng S; Fu D; He Y; Zhao Y; Wang CF; Jiang XF; Song Q; Xu PP; Zhao WL
    Clin Epigenetics; 2020 Oct; 12(1):160. PubMed ID: 33097085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma: A case report and literature review.
    Jin J; Zheng C; Wu S
    Medicine (Baltimore); 2018 Jan; 97(2):e9611. PubMed ID: 29480865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted strategies in the treatment of primary gastric lymphomas: from rituximab to recent insights into potential new drugs.
    Merchionne F; Iacopino P; Minoia C; Iacobazzi A; Rana A; Serrati S; De Tullio G; Loseto G; Lapietra A; Lucarelli A; Guarini A
    Curr Med Chem; 2014; 21(8):1005-16. PubMed ID: 23992322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse large B-cell lymphoma solely involving bilateral adrenal glands and stomach: report of an extremely rare case with review of the literature.
    Wakabayashi M; Sekiguchi Y; Shimada A; Ichikawa K; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(11):8190-7. PubMed ID: 25550871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma.
    Merz LE; Hergott CB; Zon R
    J Drugs Dermatol; 2023 Dec; 22(12):1223-1224. PubMed ID: 38051847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of relapsed and refractory EZB/C3 subtype DLBCL with chidamide in combination of R2-CHOP: a case report].
    Yang L; Zhang W; Zhang ML; Shen KF; Wang JC; Guan YQ; Cai HD; Bao YH; Xiao M; Zhou JF; Zheng M
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):436-437. PubMed ID: 34218590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.